Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
publish chart | backtests Type: candle | line | advanced    Timeframe: intraday | daily | weekly | monthly  Settings
NXTM [NASD]
Nxstage Medical, Inc.
Healthcare | Medical Appliances & Equipment | USA
financial highlights | statements
Index- P/E- EPS (ttm)-0.26 Insider Own8.35% Shs Outstand59.74M Perf Week5.46%
Market Cap807.09M Forward P/E- EPS next Y-0.10 Insider Trans-6.73% Shs Float55.56M Perf Month25.32%
Income-15.00M PEG- EPS next Q-0.07 Inst Own83.50% Short Float5.47% Perf Quarter16.77%
Sales246.83M P/S3.27 EPS this Y33.69% Inst Trans0.42% Short Ratio10.13 Perf Half Y24.17%
Book/sh3.29 P/B4.11 EPS next Y53.80% ROA-4.94% Target Price15.15 Perf Year-10.53%
Cash/sh1.67 P/C8.09 EPS next 5Y20.00% ROE-8.61% 52W Range10.15 - 17.15 Perf YTD20.09%
Dividend- P/FCF- EPS past 5Y0.00% ROI-5.62% 52W High-21.22% Beta0.62
Dividend %- Quick Ratio2.99 Sales past 5Y32.20% Gross Margin38.69% 52W Low33.10% ATR0.34
Employees2700 Current Ratio3.87 Sales Q/Q8.24% Oper. Margin-4.90% RSI (14)80.23 Volatility2.58% 2.90%
OptionableYes Debt/Eq0.01 EPS Q/Q8.81% Profit Margin-6.08% Rel Volume1.15 Prev Close13.39
ShortableYes LT Debt/Eq0.00 EarningsMay 02 BMO Payout- Avg Volume299.75K Price13.51
Recom1.80 SMA2013.50% SMA5017.86% SMA20013.94% Volume344,497 Change0.90%
03-May-13Reiterated Feltl & Co. Hold $11.50 → $12
01-Mar-13Reiterated Feltl & Co. Hold $13 → $11.50
04-Dec-12Downgrade Northland Securities Outperform → Market Perform
07-Sep-12Initiated Northland Securities Outperform $18
18-Feb-11Reiterated Rodman & Renshaw Mkt Underperform $15 → $18
03-Dec-10Initiated Jefferies Buy $27
14-Oct-10Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform $15
15-Sep-10Initiated Feltl & Co. Buy $19
26-Jul-10Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
06-May-10Reiterated Rodman & Renshaw Mkt Outperform $11 → $14
08-Jan-10Initiated Rodman & Renshaw Mkt Outperform $11
05-Jun-09Upgrade William Blair Mkt Perform → Outperform
06-Aug-08Reiterated SMH Capital Buy $8 → $7
06-Aug-08Reiterated Canaccord Adams Hold $7 → $4.75
29-Jul-08Initiated SMH Capital Buy $8
14-May-08Reiterated JMP Securities Mkt Outperform $13 → $10
13-May-08Downgrade William Blair Outperform → Mkt Perform
13-May-08Downgrade Canaccord Adams Buy → Hold $12 → $7
13-Feb-08Reiterated SMH Capital Buy $18 → $13
13-Feb-08Reiterated JMP Securities Mkt Outperform $17 → $13
21-May-13 05:10PM  InPlay: Nxstage Medical announces new agreements with DaVita Briefing.com
05:09PM  NxStage Announces New Agreements with DaVita PR Newswire
10:19AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
10-May-13 01:04PM  NXSTAGE MEDICAL, INC. Financials EDGAR Online Financials
09-May-13 08:00AM  NxStage Announces Second Quarter 2013 Investor Conference Schedule PR Newswire
04-May-13 05:16PM  5 Healthcare Stock Earnings Snapshots at Wall St. Cheat Sheet
02-May-13 02:15PM  NxStage Medical's CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
11:19AM  Nxstage Medical Earnings: Heres Why the Stock is Up Now at Wall St. Cheat Sheet
07:30AM  InPlay: Nxstage Medical reports EPS in-line, revs in-line; guides Q2 EPS below consensus, revs in-line Briefing.com
07:27AM  NxStage Reports First Quarter 2013 Financial Results PR Newswire
07:07AM  Q1 2013 NxStage Medical, Inc. Earnings Release - Before Market Open CCBN
01:44AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
01-May-13 09:19PM  NxStage Medical Earnings Preview: Get Ahead of the Analysts at Wall St. Cheat Sheet
30-Apr-13 08:02AM  InPlay: Nxstage Medical announces FDA clearance for new high flow capabilities with NxStage System One Briefing.com
08:00AM  NxStage Announces FDA Clearance for New High Flow Capabilities with NxStage System One PR Newswire
25-Apr-13 04:34PM  InPlay: Nxstage Medical names Robert Funari Chairman Of The Board Briefing.com
04:33PM  NxStage Names Robert G. Funari Chairman Of The Board PR Newswire
09:59AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
09-Apr-13 08:00AM  NxStage® to Report First Quarter Fiscal 2013 Financial Results PR Newswire
08-Apr-13 08:00AM  NxStage Completes Move to Direct Sales In UK PR Newswire
20-Mar-13 08:00AM  Home Hemodialysis Patients Urge Medicare to Fix HHD Training Reimbursement PR Newswire
19-Mar-13 11:54AM  Aligning Medical Therapies, Devices and Technologies with the Affordable Care Act and the Accountable Care Act: An Outlook for the Medical Device Sector Provided by Matt Miksic, Managing Director and Senior Research Analyst at Piper Jaffray Wall Street Transcript
13-Mar-13 01:02AM  Why Nxstage Medical May Be About to Take Off at Motley Fool
08-Mar-13 12:00PM  NxStage Educational Reception at Annual Dialysis Conference Features Celebrity and Former NxStage User Stephen Furst PR Newswire
08:00AM  Rockwell Medical Signs Supply Contract With NxStage(R) Medical Marketwired
08:00AM  Rockwell Medical Signs Supply Contract With NxStage(R) Medical Marketwire
06-Mar-13 01:04PM  NXSTAGE MEDICAL, INC. Financials EDGAR Online Financials
02-Mar-13 09:09PM  New Star Analyst Rankings for NxStage Medical, Inc. StarMine
01-Mar-13 07:28PM  New Star Analyst Rankings for NxStage Medical, Inc. StarMine
05:00PM  Nxstage Medical Reinitiated at Hold and 3 Reinitiated Ratings to Recognize at Wall St. Cheat Sheet
28-Feb-13 08:05PM  Nxstage Medical Beats on Both Top and Bottom Lines at Motley Fool
12:18PM  NxStage Medical's CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha
11:09AM  Nxstage Medical Earnings: Heres Why Investors are Buying Shares Now at Wall St. Cheat Sheet
07:27AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
07:14AM  InPlay: Nxstage Medical beats by $0.01, beats on revs; guides Q1 EPS, revs below consensus; guides FY13 EPS below consensus, revs in-line Briefing.com
07:10AM  NxStage Reports Record Fourth Quarter and Full-Year 2012 Financial Results PR Newswire
07:07AM  Q4 2012 NxStage Medical, Inc. Earnings Release - Before Market Open CCBN
25-Feb-13 08:07AM  InPlay: Nxstage Medical announces CE Mark approval, first clinical use of its single needle for dialysis patients Briefing.com
08:00AM  NxStage Announces CE Mark Approval, First Clinical Use of its Single Needle for Dialysis Patients PR Newswire
01:26AM  It's Showtime for Nxstage Medical at Motley Fool
21-Feb-13 08:05AM  InPlay: Nxstage Medical announces CE Mark approval for new high flow capabilities with System One Briefing.com
08:00AM  NxStage Announces CE Mark Approval for New High Flow Capabilities with System One PR Newswire
20-Feb-13 05:05PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
19-Feb-13 08:14AM  NxStage Medical announces CE Mark approval for noctural home hemodialysis at theflyonthewall.com
08:01AM  InPlay: Nxstage Medical Announces CE Mark Approval for Nocturnal Home Hemodialysis Briefing.com
08:00AM  NxStage Announces CE Mark Approval for Nocturnal Home Hemodialysis PR Newswire
14-Feb-13 08:00AM  NxStage Initiates 2013 'Call to Action' Campaign with Launch of Hemodialysis At Home: A Better Way For a Better Life PR Newswire
08-Feb-13 05:58PM  Covidien Issues STAR Trial Data Zacks
31-Jan-13 04:33PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
28-Jan-13 08:31AM  NxStage Home Hemodialysis Patient Awareness Tour Kicks Off January 29th PR Newswire
25-Jan-13 04:37PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financ EDGAR Online
02:36PM  Covidien's 1Q Beats, Raises View Zacks
24-Jan-13 12:45PM  Robert Funari Joins NxStage Board of Directors PR Newswire
18-Jan-13 08:00AM  NxStage® to Report Fourth Quarter and Full Year 2012 Financial Results PR Newswire
15-Jan-13 01:58PM  LabCorp Remains at Neutral Zacks
12:48PM  Quest Diagnostics Remains at Neutral Zacks
11-Jan-13 10:18AM  Volcano Corporation Stays Neutral Zacks
04-Jan-13 05:01PM  1 Reason Nxstage Medical's Earnings Aren't So Hot at Motley Fool
04:55PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
03-Jan-13 11:31AM  U.S. Demographic Growth Investment Strategies: Interview with Richard K. Matros, Sabra Health Care REIT (SBRA) Inc.'s Chairman, President and Chief Executive Officer Wall Street Transcript
21-Dec-12 05:08PM  A Hidden Reason Nxstage Medical's Future Looks Bright at Motley Fool
18-Dec-12 08:00AM  NxStage to Present at the 31st Annual J.P. Morgan Healthcare Conference PR Newswire
05-Dec-12 06:05PM  Nasdaq stocks posting largest percentage decreases AP
01:27PM  Nasdaq stocks posting largest percentage decreases AP
04-Dec-12 06:02PM  Nasdaq stocks posting largest percentage decreases AP -6.59%
03:19PM  Why NxStage Medical Shares Dropped at Motley Fool
03:01PM  Cott Downgraded to Hold and 3 Downgraded Stocks to Eye at Wall St. Cheat Sheet
01:25PM  Nasdaq stocks posting largest percentage decreases AP
01:17PM  Cott Downgraded to Hold and 3 Downgraded Stocks to Eye at Wall St. Cheat Sheet
01:01PM  Shire Plc and Other Healthcare Stocks Making Big Moves on December 4, 2012 at Investopedia
03-Dec-12 10:53PM  Nxstage Medical downgraded by Northland Securities Briefing.com
26-Nov-12 12:22PM  Will Baxter Go For Gambro? at Investopedia
14-Nov-12 01:04PM  NXSTAGE MEDICAL, INC. Financials EDGAR Online Financials
10-Nov-12 09:29AM  New Star Analyst Rankings for NxStage Medical, Inc. StarMine
09-Nov-12 12:32PM  Healthcare Stocks, Including Covidien, Making Big Moves on November 9, 2012 at Investopedia -6.22%
09:32AM  New Star Analyst Rankings for NxStage Medical, Inc. StarMine
09:29AM  Nxstage Medical Beats Up on Analysts Yet Again at Motley Fool
08:37AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financ EDGAR Online
08:30AM  Jean Mixer Joins NxStage Board of Directors PR Newswire
08:00AM  NxStage Announces Fourth Quarter 2012 Investor Conference Schedule PR Newswire
08-Nov-12 12:30PM  HCA and Other Healthcare Stocks Making Big Moves on November 8, 2012 at Investopedia +10.56%
11:41AM  Why Nxstage Medical Shares Sank at Motley Fool
09:12AM  2 Biotech Companies With Positive Results That May Be Headed In Opposite Directions at Seeking Alpha
07:43AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
07:40AM  InPlay: Nxstage Medical beats by $0.02, reports revs in-line; guides Q4 EPS in-line, revs in-line Briefing.com
07:30AM  NxStage Reports Record Revenue for the Third Quarter of Fiscal 2012 PR Newswire
07:07AM  Q3 2012 NxStage Medical, Inc. Earnings Release - Before Market Open CCBN
16-Oct-12 09:17AM  Governor Deval Patrick joins celebration of NxStage's new headquarters, applauds Company's commitment to growth in Massachusetts PR Newswire
15-Oct-12 12:52PM  NxStage Medical doubles Lawrence HQ at bizjournals.com
12-Oct-12 04:15PM  Recording Artist and Patient Advocate David RUSH Joins NxStage to Raise Awareness of HHD at National Kidney Foundation Kidney Walk PR Newswire
11-Oct-12 06:04PM  Casey Analyst Forecasts Explosive Biotech Growth at Seeking Alpha
09-Oct-12 08:00AM  NxStage® to Report Third Quarter Fiscal 2012 Financial Results PR Newswire
08-Oct-12 04:32PM  3 Stocks to Watch Right Now at Motley Fool
04:30PM  NxStage Joins Home Dialyzors United Conference to Drive More Awareness of Home Hemodialysis PR Newswire
05-Oct-12 02:53PM  NxStage Applauds Journal Article Urging Greater Use of Home Hemodialysis and Removal of Barriers that Deny Patients Access to Life-Altering Treatment Option PR Newswire
28-Sep-12 12:34PM  Top 10 Cash Offender Countdown: No. 6 to No. 4 at Motley Fool
20-Sep-12 11:38AM  How Long Does It Take to Make a Buck at Nxstage Medical? at Motley Fool
10-Sep-12 08:36AM  NxStage Names Todd M. Snell Senior Vice President of Quality Assurance, Regulatory & Clinical Affairs PR Newswire
07-Sep-12 01:48PM  Heartware INITIATED at Under Perform and 3 Analyst-Initiated Shares to Notice at Wall St. Cheat Sheet
10:20AM  Equity Brief: Upgrades and Downgrades for September 7th: MLNX, MN, MPR, MTSI, MUSA, NSC, NUVA, NVDA, NXTM Thomson Reuters ONE
NxStage Medical, Inc., a medical device company, develops, manufactures, and markets products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures. The company operates in two segments, System One and In-Center. Its primary product, the NxStage System One, is a portable hemodialysis system used for home hemodialysis and a range of dialysis therapies for chronic home hemodialysis treatment, and the treatment of acute and chronic kidney failure and fluid overload. The NxStage System One comprises components, such as The NxStage Cycler, a compact portable electromechanical device; The NxStage Cartridge, a single-use integrated treatment cartridge; and premixed dialysate for hemodialysis applications. The company also sells a line of extracorporeal disposable products for use primarily for in-center dialysis treatments for patients with end-stage renal disease (ESRD); and needles and blood tubing sets primarily to dialysis clinics for the treatment of ESRD. NxStage Medical, Inc. markets its products primarily to dialysis clinics, nephrologists, and hospitals through distributors and sales representatives in the United States, Mexico, and Europe. The company was formerly known as QB Medical, Inc. and changed its name to NxStage Medical, Inc. NxStage Medical, Inc. was founded in 1998 and is headquartered in Lawrence, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shea ThomasSVP Manufacturing OperationsMay 13Option Exercise2.115,72412,07835,795May 14 04:27 PM
Shea ThomasSVP Manufacturing OperationsMay 13Sale12.6715,724199,15120,071May 14 04:27 PM
MOORE CRAIG WDirectorMar 13Option Exercise5.3914,00075,46091,387Mar 14 04:50 PM
Giannini Daniel ADirectorMar 12Option Exercise5.3914,00075,46060,260Mar 13 08:45 AM
Snell Todd MSVP, QA, Reg.&Clinical AffairsMar 11Sale10.984274,6886,903Mar 12 04:52 PM
Burbank Jeffrey HPresident & CEOMar 09Option Exercise0.008,4040592,486Mar 12 04:27 PM
Brown Robert S.Sr. Vice President, CFOMar 09Option Exercise0.003,056033,521Mar 12 04:28 PM
Shea ThomasSVP Manufacturing OperationsMar 09Option Exercise0.002,445030,848Mar 12 04:30 PM
Swan Winifred LSVP and General CounselMar 09Option Exercise0.003,056020,374Mar 12 04:31 PM
Turk Joseph E JrPresident, North AmericaMar 09Option Exercise0.003,0560111,213Mar 12 04:33 PM
REID PERPERDirectorMar 05Option Exercise5.3914,00075,460109,778Mar 06 06:29 PM
Burbank Jeffrey HPresident & CEOMar 04Option Exercise0.0010,1060596,185Mar 06 06:21 PM
Brown Robert S.Sr. Vice President, CFOMar 04Option Exercise0.003,675034,819Mar 06 06:19 PM
Turk Joseph E JrPresident, North AmericaMar 04Option Exercise0.003,6750113,557Mar 06 06:23 PM
Swan Winifred LSVP and General CounselMar 04Option Exercise0.003,675021,520Mar 06 06:24 PM
Shea ThomasSVP Manufacturing OperationsMar 04Option Exercise0.002,939031,960Mar 06 06:25 PM
Turk Joseph E JrPresident, North AmericaJan 30Option Exercise4.105,98924,55598,443Jan 31 05:03 PM
Miller MichaelPresident, InternationalJan 25Option Exercise0.001,250011,375Jan 25 04:51 PM
Utterberg David SDirectorJan 03Sale11.1410,800120,3603,893,818Jan 03 07:21 PM
Utterberg David SDirectorJan 02Sale11.2926,532299,4913,904,618Jan 02 07:15 PM
Turk Joseph E JrPresident, North AmericaDec 31Option Exercise0.0011,981096,252Jan 03 06:38 PM
Swan Winifred LSVP and General CounselDec 31Option Exercise0.0011,981013,248Jan 03 06:37 PM
Shea ThomasSVP Manufacturing OperationsDec 31Option Exercise0.009,338025,030Jan 03 06:37 PM
Brown Robert S.Sr. Vice President, CFODec 31Option Exercise0.0011,981027,116Jan 03 06:34 PM
Burbank Jeffrey HPresident & CEODec 31Option Exercise2.0772,328149,896577,252Jan 03 06:36 PM
Utterberg David SDirectorDec 31Sale11.159,669107,8343,930,262Jan 02 07:15 PM
Turk Joseph E JrPresident, North AmericaDec 28Option Exercise4.106,00024,60084,271Jan 02 05:37 PM
Utterberg David SDirectorDec 20Sale11.0514,713162,6273,939,931Dec 21 04:31 PM
Utterberg David SDirectorDec 19Sale11.1014,140156,9583,954,644Dec 19 06:29 PM
Utterberg David SDirectorDec 18Sale11.3415,918180,5263,968,784Dec 19 06:29 PM
Utterberg David SDirectorDec 17Sale11.3021,322241,0053,984,702Dec 19 06:29 PM
Utterberg David SDirectorDec 14Sale11.1821,631241,9044,006,024Dec 14 05:13 PM
Utterberg David SDirectorDec 13Sale11.0810,560117,0544,027,655Dec 14 05:13 PM
Utterberg David SDirectorDec 12Sale11.2918,822212,5464,038,215Dec 14 05:13 PM
Utterberg David SDirectorDec 11Sale11.5037,311429,2484,057,037Dec 11 05:19 PM
Utterberg David SDirectorDec 10Sale11.0612,602139,4184,094,348Dec 11 05:19 PM
Utterberg David SDirectorDec 07Sale11.0211,347125,0704,106,950Dec 11 05:19 PM
Utterberg David SDirectorDec 06Sale11.1221,174235,3574,118,297Dec 06 06:53 PM
Utterberg David SDirectorDec 05Sale11.4732,274370,1254,139,471Dec 06 06:53 PM
Utterberg David SDirectorDec 04Sale11.1182,907921,1384,171,745Dec 06 06:53 PM
Utterberg David SDirectorDec 03Sale12.0626,325317,4564,254,652Dec 03 05:47 PM
Utterberg David SDirectorNov 30Sale11.9919,973239,5684,280,977Dec 03 05:47 PM
Utterberg David SDirectorNov 29Sale12.1321,346258,9824,300,950Dec 03 05:47 PM
Utterberg David SDirectorNov 28Sale11.8817,748210,8994,322,296Nov 28 05:17 PM
Utterberg David SDirectorNov 27Sale11.5624,338281,4034,340,044Nov 28 05:17 PM
Utterberg David SDirectorNov 26Sale11.7319,802232,2524,364,382Nov 28 05:17 PM
Utterberg David SDirectorNov 23Sale11.7110,023117,3564,384,184Nov 26 04:59 PM
Utterberg David SDirectorNov 21Sale11.6117,622204,5474,394,207Nov 26 04:59 PM
Utterberg David SDirectorNov 20Sale11.2614,501163,2934,411,829Nov 21 05:57 PM
Utterberg David SDirectorNov 19Sale11.1713,083146,1374,426,330Nov 21 05:57 PM
Utterberg David SDirectorNov 16Sale11.001,40015,4024,439,413Nov 16 05:07 PM
Utterberg David SDirectorNov 15Sale11.049,861108,9024,440,813Nov 16 05:07 PM
Utterberg David SDirectorNov 14Sale11.4025,668292,5414,450,674Nov 16 05:07 PM
Utterberg David SDirectorNov 13Sale11.7439,957469,1834,476,342Nov 13 07:19 PM
Utterberg David SDirectorNov 12Sale11.4830,481349,7884,516,299Nov 13 07:19 PM
Utterberg David SDirectorNov 09Sale11.1330,528339,9054,546,780Nov 13 07:19 PM
Utterberg David SDirectorNov 08Sale11.7183,238974,7604,577,308Nov 13 07:19 PM
Utterberg David SDirectorNov 06Sale11.032,27625,0954,660,546Nov 07 05:41 PM
Utterberg David SDirectorNov 05Sale11.094,96054,9994,662,822Nov 07 05:41 PM
Utterberg David SDirectorNov 02Sale11.1514,124157,4734,667,782Nov 02 05:38 PM
Utterberg David SDirectorNov 01Sale11.1314,313159,3094,681,906Nov 02 05:38 PM
Utterberg David SDirectorOct 31Sale11.096,29369,7674,696,219Nov 02 05:38 PM
Utterberg David SDirectorOct 26Sale11.2210,827121,4914,702,512Oct 30 05:14 PM
Utterberg David SDirectorOct 25Sale11.3925,146286,4684,713,339Oct 26 05:00 PM
Miller MichaelPresident, InternationalOct 24Option Exercise0.001,250010,125Oct 26 04:58 PM
Utterberg David SDirectorOct 24Sale11.2036,545409,4324,738,485Oct 26 05:00 PM
Utterberg David SDirectorOct 23Sale11.2740,621457,8804,775,030Oct 23 06:24 PM
Utterberg David SDirectorOct 22Sale11.5328,584329,5764,815,651Oct 23 06:24 PM
Utterberg David SDirectorOct 19Sale11.9421,383255,2944,844,235Oct 23 06:24 PM
Utterberg David SDirectorOct 18Sale12.2519,220235,4124,865,618Oct 18 05:24 PM
Utterberg David SDirectorOct 17Sale12.2620,655253,2534,884,838Oct 18 05:24 PM
Utterberg David SDirectorOct 16Sale12.3711,857146,6534,905,493Oct 18 05:24 PM
Swan Winifred LSVP and General CounselSep 17Sale12.963,00038,8671,267Sep 18 05:08 PM
Burbank Jeffrey HPresident & CEOSep 12Option Exercise8.5537,000316,350504,924Sep 12 04:40 PM
Turk Joseph E JrPresident, North AmericaSep 07Option Exercise8.558427,19978,271Sep 11 04:55 PM
Swan Winifred LSVP and General CounselAug 14Sale13.623,00040,8604,267Aug 16 04:45 PM
Shea ThomasSVP Manufacturing OperationsAug 06Option Exercise4.324,00017,28020,692Aug 08 04:31 PM
Shea ThomasSVP Manufacturing OperationsAug 06Sale15.005,00075,00515,692Aug 08 04:31 PM
Miller MichaelPresident, InternationalJul 30Sale15.534136,4148,875Aug 01 04:41 PM
Miller MichaelPresident, InternationalJul 25Option Exercise0.001,25009,288Jul 25 04:56 PM
Turk Joseph E JrPresident, North AmericaJul 18Option Exercise3.451,7756,11981,454Jul 19 05:30 PM
Turk Joseph E JrPresident, North AmericaJul 18Sale15.544,02562,53677,429Jul 19 05:30 PM
Burbank Jeffrey HPresident & CEOJul 13Option Exercise8.559,25079,088477,174Jul 13 05:27 PM
Burbank Jeffrey HPresident & CEOJul 13Sale15.899,250146,941467,924Jul 13 05:27 PM
Swan Winifred LSVP and General CounselJul 13Sale15.883,00047,6547,267Jul 13 05:16 PM
Burbank Jeffrey HPresident & CEOJul 12Option Exercise8.559,25079,088477,174Jul 13 05:27 PM
Burbank Jeffrey HPresident & CEOJul 12Sale15.489,250143,172467,924Jul 13 05:27 PM
Burbank Jeffrey HPresident & CEOJul 11Sale15.555,00077,750467,924Jul 13 05:27 PM
Shea ThomasSVP Manufacturing OperationsJul 09Option Exercise2.114,0008,44026,692Jul 10 04:43 PM
Shea ThomasSVP Manufacturing OperationsJul 09Sale16.1510,000161,53316,692Jul 10 04:43 PM
Swan Winifred LSVP and General CounselJul 02Option Exercise4.912,54112,46612,808Jul 03 07:44 PM
Swan Winifred LSVP and General CounselJul 02Sale16.502,54141,92710,267Jul 03 07:44 PM
Turk Joseph E JrPresident, North AmericaJun 29Option Exercise8.553,68431,49883,363Jul 03 07:43 PM
Turk Joseph E JrPresident, North AmericaJun 29Sale16.623,68461,24279,679Jul 03 07:43 PM
Turk Joseph E JrPresident, North AmericaJun 21Option Exercise3.451,7756,11983,704Jun 21 07:01 PM
Turk Joseph E JrPresident, North AmericaJun 21Sale15.874,02563,87779,679Jun 21 07:01 PM
Burbank Jeffrey HPresident & CEOJun 21Sale15.835,00079,135472,924Jun 21 05:22 PM
Burbank Jeffrey HPresident & CEOJun 20Option Exercise8.559,25079,088487,174Jun 21 05:22 PM
Burbank Jeffrey HPresident & CEOJun 20Sale16.309,250150,792477,924Jun 21 05:22 PM
Burbank Jeffrey HPresident & CEOJun 19Option Exercise8.559,25079,088487,174Jun 21 05:22 PM
open in yahoo | open in reuters | open in google